Inhibition of KL-6/MUC1 glycosylation limits aggressive progression of pancreatic cancer

Figure 5 Effects of glycosylation inhibitors on Panc-1 and Capan-1 cell invasion. Microscopic images of A-C: Panc-1; or D-F: Capan-1 cells. A, D: Controls; B, E: 48 h treatment with 2.0 mg% tunicamycin; C, F: 48 h treatment with 5.0 mmol/L benzyl-N-acetyl-α-galactosaminide (200 × magnification); G, H: Invasive rates; ^aP < 0.05 vs control; ^cP < 0.05 vs tunicamycin.